ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Dowski
|
518 |
164K |
22 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
518
|
164K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Dowski
|
518 |
164K |
16 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
518
|
164K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Dowski
|
204 |
72K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
72K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Dowski
|
601 |
234K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
601
|
234K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Dowski
|
601 |
234K |
63 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
601
|
234K
|
63
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Dowski
|
601 |
234K |
9 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
601
|
234K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Dowski
|
549 |
174K |
25 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
174K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Dowski
|
601 |
234K |
36 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
601
|
234K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2024 Half Year Financial Results Webcast
|
|
Dowski
|
62 |
23K |
19 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
62
|
23K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
Dowski
|
78 |
24K |
18 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
24K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
8 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
26 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Dowski
|
102 |
38K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
102
|
38K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Dowski
|
362 |
118K |
9 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
362
|
118K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Dowski
|
716 |
200K |
7 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
716
|
200K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
11 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Launches Entitlement Offer and Placement
|
|
Dowski
|
166 |
50K |
2 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
166
|
50K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Dowski
|
17K |
6.6M |
6 |
08/10/23 |
08/10/23 |
ASX - By Stock
|
17K
|
6.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Dowski
|
1.0K |
394K |
17 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
394K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Dowski
|
1.0K |
394K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
394K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Dowski
|
3.4K |
1.1M |
4 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Dowski
|
3.4K |
1.1M |
7 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Dowski
|
17K |
6.6M |
49 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
17K
|
6.6M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Dowski
|
3.4K |
1.1M |
10 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Dowski
|
3.4K |
1.1M |
3 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
4 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
9.6K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Dowski
|
5.2K |
2.6M |
12 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
5.2K
|
2.6M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
Dowski
|
618 |
236K |
7 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
618
|
236K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
GVHD the first step
|
|
Dowski
|
239 |
66K |
45 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
239
|
66K
|
45
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Dowski
|
5.2K |
2.6M |
5 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
5.2K
|
2.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Dowski
|
1.0K |
328K |
16 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
1.0K
|
328K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO First Quarter Results and 2022 AGM Presentation
|
|
Dowski
|
6 |
2.9K |
4 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
6
|
2.9K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Dowski
|
576 |
203K |
7 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
203K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
5 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
9.6K
|
2.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Time is coming
|
|
Dowski
|
252 |
88K |
6 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
252
|
88K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Dowski
|
9.6K |
2.8M |
7 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
9.6K
|
2.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Dowski
|
1.1K |
343K |
2 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
1.1K
|
343K
|
2
|
|
ASX - By Stock
|
HTG |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Dowski
|
130 |
46K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
130
|
46K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Dowski
|
1.1K |
343K |
2 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
1.1K
|
343K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Dowski
|
880 |
213K |
5 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
880
|
213K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Presents at Edison Group Global Healthcare Conference
|
|
Dowski
|
267 |
64K |
50 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
267
|
64K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Dowski
|
211 |
73K |
10 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
73K
|
10
|
|
ASX - By Stock
|
HTG |
Re:
TA CHART
|
|
Dowski
|
740 |
241K |
17 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
740
|
241K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Dowski
|
1.0K |
275K |
15 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
275K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Dowski
|
1.0K |
275K |
2 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
275K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Dowski
|
17K |
6.6M |
4 |
14/11/21 |
14/11/21 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
Dowski
|
145 |
41K |
6 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
145
|
41K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
Dowski
|
206 |
62K |
15 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
206
|
62K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Dowski
|
4.7K |
1.1M |
1 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
1
|
|